Acute myeloid leukaemia (AML) is a heterogenous clonal hematopoietic malignancy primarily treated with combination of cytarabine (ara-C) and anthracyclines. Despite high remission rates. especially in younger patients. a vast majority of patients die due to relapse or chemotherapy/stem cell transplantation-related toxicity. https://www.socialstudiesscholar.com/